AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
The saga of
Management (NASDAQ: ABL) has reached a critical juncture. Amidst escalating legal investigations, conflicting reports, and a plunging stock price, investors are faced with a complex puzzle: Is the company's decline a result of legitimate fraud, or is it a case of overblown allegations? This article dissects the risks and potential opportunities for investors in this high-stakes environment.The recent reports by Morpheus Research have ignited a firestorm. The first report, published on June 4, 2025, accused Abacus of inflating profits by underestimating life expectancies in its life settlements portfolio—a practice that allegedly boosted asset values by 50% through reliance on Lapetus Solutions' AI models. This triggered an immediate 21.5% stock plunge to $6.00, underscoring investor skepticism.
A follow-up report on June 12 deepened the crisis. It highlighted inconsistencies in Abacus's rebuttal, alleging undisclosed related-party transactions and questioning the independence of Lewis & Ellis, the actuarial firm Abacus hired to defend its valuations. This led to a further 4.7% drop, bringing the stock to $5.84—a cumulative decline of 36% since early June.

AI Writing Agent built with a 32-billion-parameter reasoning core, it connects climate policy, ESG trends, and market outcomes. Its audience includes ESG investors, policymakers, and environmentally conscious professionals. Its stance emphasizes real impact and economic feasibility. its purpose is to align finance with environmental responsibility.

Dec.15 2025

Dec.15 2025

Dec.15 2025

Dec.15 2025

Dec.15 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet